MCID: ART013
MIFTS: 22

Aortic Malignant Tumor

Categories: Cancer diseases, Cardiovascular diseases

Aliases & Classifications for Aortic Malignant Tumor

MalaCards integrated aliases for Aortic Malignant Tumor:

Name: Aortic Malignant Tumor 12 15
Aortic Malignant Neoplasm 12
Malignant Aortic Neoplasm 71

Classifications:



External Ids:

Disease Ontology 12 DOID:8352
NCIt 49 C5375
UMLS 71 C1334560

Summaries for Aortic Malignant Tumor

Disease Ontology : 12 A vascular cancer that is located in the aorta.

MalaCards based summary : Aortic Malignant Tumor, also known as aortic malignant neoplasm, is related to pancreatic serous cystadenocarcinoma and intrahepatic bile duct adenoma. An important gene associated with Aortic Malignant Tumor is KRT20 (Keratin 20), and among its related pathways/superpathways is NF-kappaB Signaling. Affiliated tissues include aorta, breast and heart.

Related Diseases for Aortic Malignant Tumor

Diseases related to Aortic Malignant Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 300, show less)
# Related Disease Score Top Affiliating Genes
1 pancreatic serous cystadenocarcinoma 10.3 KRT7 KRT20
2 intrahepatic bile duct adenoma 10.3 KRT7 KRT20
3 bile duct adenoma 10.3 KRT7 KRT20
4 gastric signet ring cell adenocarcinoma 10.3 KRT7 KRT20
5 nephrogenic adenoma of urinary bladder 10.3 KRT7 KRT20
6 ovarian large-cell neuroendocrine carcinoma 10.3 KRT7 KRT20
7 atrophic vulva 10.3 KRT7 KRT20
8 small cell carcinoma of the bladder 10.3 KRT7 KRT20
9 urinary bladder small cell neuroendocrine carcinoma 10.3 KRT7 KRT20
10 cystitis cystica 10.3 KRT7 KRT20
11 eyelid carcinoma 10.3 KRT7 KRT20
12 jejunal cancer 10.3 KRT7 KRT20
13 intratubular embryonal carcinoma 10.3 KRT7 KRT20
14 papillary transitional carcinoma 10.3 KRT7 KRT20
15 ovarian brenner tumor 10.3 KRT7 KRT20
16 glandular cystitis 10.3 KRT7 KRT20
17 nephrogenic adenoma of the urethra 10.3 KRT7 KRT20
18 mucinous stomach adenocarcinoma 10.3 KRT7 KRT20
19 thymus clear cell carcinoma 10.2 KRT7 KRT20
20 bladder lateral wall cancer 10.2 KRT7 KRT20
21 lung acinar adenocarcinoma 10.2 KRT7 KRT20
22 papillary cystadenocarcinoma 10.2 KRT7 KRT20
23 prostate neuroendocrine neoplasm 10.2 KRT7 KRT20
24 bladder adenocarcinoma 10.2 KRT7 KRT20
25 ovarian mucinous adenocarcinoma 10.2 KRT7 KRT20
26 breast osteosarcoma 10.2 KRT7 KRT20
27 bladder clear cell adenocarcinoma 10.2 KRT7 KRT20
28 clear cell adenocarcinoma 10.2 KRT7 KRT20
29 urethra clear cell adenocarcinoma 10.2 KRT7 KRT20
30 cystic basal cell carcinoma 10.2 KRT7 KRT20
31 chronic cystitis 10.2 KRT7 KRT20
32 cutaneous ganglioneuroma 10.2 KRT20 CD34
33 horseshoe kidney 10.2 KRT7 KRT20
34 bladder benign neoplasm 10.2 KRT7 KRT20
35 medulloepithelioma 10.2 KRT7 KRT20
36 lymphoepithelioma-like carcinoma 10.2 KRT7 KRT20
37 central nervous system fibrosarcoma 10.2 KRT7 CD34
38 breast hemangiopericytoma 10.2 KRT7 CD34
39 nephrogenic adenofibroma 10.2 KRT7 CD34
40 mediastinum sarcoma 10.2 MDM2 KRT7
41 basaloid squamous cell carcinoma 10.2 KRT7 KRT20
42 metatypical basal cell carcinoma 10.2 KRT7 CD34
43 mesenchymoma 10.2 MDM2 CD34
44 collecting duct carcinoma 10.2 KRT7 KRT20
45 ampulla of vater adenocarcinoma 10.2 KRT7 KRT20
46 inverted papilloma 10.1 KRT7 KRT20
47 gastric liposarcoma 10.1 MDM2 CD34
48 bladder leiomyoma 10.1 KRT7 CD34
49 mucinous tubular and spindle renal cell carcinoma 10.1 KRT7 CD34
50 sclerosing liposarcoma 10.1 MDM2 CD34
51 spindle cell liposarcoma 10.1 MDM2 CD34
52 breast leiomyosarcoma 10.1 KRT7 CD34
53 pediatric liposarcoma 10.1 MDM2 CD34
54 inflammatory liposarcoma 10.1 MDM2 CD34
55 large cell neuroendocrine carcinoma 10.1 KRT7 KRT20
56 adult mesoblastic nephroma 10.1 KRT7 CD34
57 pleomorphic lipoma 10.1 MDM2 CD34
58 mammary paget's disease 10.1 KRT7 KRT20
59 monophasic synovial sarcoma 10.1 KRT7 CD34
60 extraosseous osteosarcoma 10.1 MDM2 CD34
61 epithelioid cell synovial sarcoma 10.1 KRT7 CD34
62 malignant mesenchymoma 10.1 MDM2 CD34
63 mixed liposarcoma 10.1 MDM2 CD34
64 retroperitoneal sarcoma 10.1 MDM2 CD34
65 spindle cell lipoma 10.1 MDM2 CD34
66 lymphangioma 10.1 PECAM1 CD34
67 infiltrating angiolipoma 10.1 MDM2 CD34
68 middle ear adenocarcinoma 10.1 PECAM1 KRT7
69 skin epithelioid hemangioma 10.1 PECAM1 CD34
70 prostate angiosarcoma 10.1 PECAM1 CD34
71 central nervous system angiosarcoma 10.1 PECAM1 CD34
72 conventional fibrosarcoma 10.1 MDM2 CD34
73 intravascular angioleiomyoma 10.1 PECAM1 CD34
74 heart fibrosarcoma 10.1 PECAM1 CD34
75 central nervous system hemangioma 10.1 PECAM1 CD34
76 ovarian angiosarcoma 10.1 PECAM1 CD34
77 conventional angiosarcoma 10.1 PECAM1 CD34
78 angiomyoma 10.1 PECAM1 CD34
79 gallbladder leiomyosarcoma 10.1 PECAM1 CD34
80 pediatric angiosarcoma 10.1 PECAM1 CD34
81 hemangioma of spleen 10.1 PECAM1 CD34
82 ovary sarcoma 10.1 PECAM1 CD34
83 thoracic benign neoplasm 10.1 KRT7 CD34
84 villous adenoma 10.0 KRT20 CEACAM5
85 breast benign neoplasm 10.0 KRT7 CD34
86 benign perivascular tumor 10.0 PECAM1 CD34
87 respiratory system benign neoplasm 10.0 KRT7 CD34
88 kaposiform hemangioendothelioma 10.0 PECAM1 CD34
89 intravascular fasciitis 10.0 PECAM1 CD34
90 pancreatic ductal carcinoma 10.0 KRT7 KRT20
91 retroperitoneal hemangiopericytoma 10.0 PECAM1 CD34
92 erythema elevatum diutinum 10.0 PECAM1 CD34
93 spleen cancer 10.0 PECAM1 CD34
94 hobnail hemangioma 10.0 PECAM1 CD34
95 breast hemangioma 10.0 PECAM1 CD34
96 breast angiosarcoma 10.0 PECAM1 CD34
97 lymphangiosarcoma 10.0 PECAM1 CD34
98 vulvar leiomyoma 10.0 PECAM1 CD34
99 glomeruloid hemangioma 10.0 PECAM1 CD34
100 skin sarcoma 10.0 PECAM1 CD34
101 bacillary angiomatosis 10.0 PECAM1 CD34
102 histiocytoid hemangioma 10.0 PECAM1 CD34
103 glomangioma 10.0 PECAM1 CD34
104 angiokeratoma circumscriptum 10.0 PECAM1 CD34
105 capillary lymphangioma 10.0 PECAM1 CD34
106 thymus adenocarcinoma 10.0 KRT20 CEACAM5
107 skin benign neoplasm 10.0 KRT20 CD34
108 dysgerminoma 10.0 KRT7 KRT20
109 subungual glomus tumor 10.0 PECAM1 CD34
110 synovium cancer 10.0 KRT7 CD34
111 breast sarcoma 10.0 PECAM1 CD34
112 glomangiomatosis 10.0 PECAM1 CD34
113 bartonellosis 10.0 PECAM1 CD34
114 cystic lymphangioma 10.0 PECAM1 CD34
115 ovarian cystadenoma 10.0 KRT7 CEACAM5
116 syringoma 10.0 KRT7 CEACAM5
117 dermis tumor 10.0 PECAM1 CD34
118 malignant spiradenoma 10.0 KRT7 CEACAM5
119 ureter adenocarcinoma 10.0 KRT7 CEACAM5
120 cutaneous mucoepidermoid carcinoma 10.0 KRT7 CEACAM5
121 follicular dendritic cell sarcoma 10.0 MDM2 CD34
122 pancreatic foamy gland adenocarcinoma 10.0 KRT7 CEACAM5
123 mucinous adenofibroma 10.0 KRT7 CEACAM5
124 capillary disease 10.0 PECAM1 CD34
125 apocrine adenoma 10.0 KRT7 CEACAM5
126 vulval paget's disease 9.9 KRT7 CEACAM5
127 sigmoid neoplasm 9.9 KRT7 CEACAM5
128 mucinous intrahepatic cholangiocarcinoma 9.9 KRT7 CEACAM5
129 eccrine adenocarcinoma 9.9 KRT7 CEACAM5
130 renal pelvis adenocarcinoma 9.9 KRT7 CEACAM5
131 external ear carcinoma 9.9 KRT7 CEACAM5
132 anal paget's disease 9.9 KRT7 CEACAM5
133 capillary hemangioma 9.9 PECAM1 CD34
134 appendiceal neoplasm 9.9 KRT7 CEACAM5
135 eccrine papillary adenocarcinoma 9.9 KRT7 CEACAM5
136 papillary adenocarcinoma 9.9 KRT7 CEACAM5
137 biliary papillomatosis 9.9 KRT7 CEACAM5
138 drug-induced lupus erythematosus 9.9 PECAM1 CD34
139 bile duct mucoepidermoid carcinoma 9.9 KRT7 CEACAM5
140 intussusception 9.9 PECAM1 CD34
141 clear cell hidradenoma 9.9 KRT7 CEACAM5
142 hidradenoma 9.9 KRT7 CEACAM5
143 hidrocystoma 9.9 KRT7 CEACAM5
144 lipomatosis, multiple 9.9 MDM2 CD34
145 pericardium cancer 9.9 KRT7 CEACAM5
146 jejunal neoplasm 9.9 KRT7 KRT20 CD34
147 eccrine acrospiroma 9.9 KRT7 CEACAM5
148 malignant fibroxanthoma 9.9 MDM2 CD34
149 eccrine sweat gland neoplasm 9.9 KRT7 CEACAM5
150 biliary tract benign neoplasm 9.9 KRT7 CEACAM5
151 warthin tumor 9.9 KRT7 CEACAM5
152 central epithelioid sarcoma 9.9 KRT7 KRT20 CD34
153 eccrine porocarcinoma 9.9 KRT7 CEACAM5
154 vulvar proximal-type epithelioid sarcoma 9.9 KRT7 KRT20 CD34
155 spindle cell carcinoma 9.9 KRT7 CD34
156 esophageal adenosquamous carcinoma 9.9 KRT7 CEACAM5
157 colon leiomyosarcoma 9.9 CEACAM5 CD34
158 vagina leiomyoma 9.9 CEACAM5 CD34
159 mesenchymal cell neoplasm 9.9 PECAM1 CD34
160 nasal cavity olfactory neuroblastoma 9.9 KRT7 CEACAM5
161 parasagittal meningioma 9.9 CEACAM5 CD34
162 cutaneous adenocystic carcinoma 9.9 KRT7 CEACAM5
163 benign peritoneal mesothelioma 9.9 KRT7 CEACAM5
164 apocrine sweat gland neoplasm 9.9 KRT7 CEACAM5
165 secretory meningioma 9.9 KRT7 CEACAM5
166 ovarian germ cell cancer 9.9 KRT7 CEACAM5
167 ovarian endometrial cancer 9.9 KRT7 CEACAM5
168 klatskin's tumor 9.9 KRT7 CEACAM5
169 lung benign neoplasm 9.9 KRT7 KRT20
170 peritoneum cancer 9.9 KRT7 CEACAM5
171 transitional cell carcinoma 9.9 MDM2 KRT7 KRT20
172 endocervical carcinoma 9.9 KRT7 CEACAM5
173 anus cancer 9.9 KRT7 CEACAM5
174 mature teratoma 9.8 KRT7 CEACAM5
175 duodenum disease 9.8 KRT7 CEACAM5
176 cecal disease 9.8 KRT7 CEACAM5
177 duodenum cancer 9.8 KRT7 CEACAM5
178 eccrine mixed tumor of skin 9.8 PECAM1 CEACAM5
179 sweat gland disease 9.8 KRT7 CEACAM5
180 cardiovascular organ benign neoplasm 9.8 PECAM1 CD34
181 colon sarcoma 9.8 CEACAM5 CD34
182 fibrous histiocytoma 9.8 PECAM1 CD34
183 spindle cell sarcoma 9.8 MDM2 KRT7 CD34
184 well-differentiated liposarcoma 9.8 MDM2 KRT7 CD34
185 sex cord-gonadal stromal tumor 9.8 KRT7 CEACAM5
186 tonsil cancer 9.8 KRT7 CEACAM5
187 lymphangitis 9.8 PECAM1 CEACAM5
188 sarcoma, synovial 9.8 MDM2 KRT7 CD34
189 bladder urothelial carcinoma 9.8 MDM2 KRT7 KRT20
190 malignant peripheral nerve sheath tumor 9.8 MDM2 KRT7 CD34
191 hemangioma 9.7 PECAM1 KRT7 CD34
192 benign mesenchymoma 9.7 PECAM1 KRT7 CD34
193 adenoid cystic carcinoma 9.7 MDM2 KRT7 KRT20
194 epithelioid sarcoma 9.7 PECAM1 KRT7 CD34
195 cardiovascular cancer 9.7 PECAM1 KRT7 CD34
196 vascular cancer 9.7 PECAM1 KRT7 CD34
197 fibroma 9.7 PECAM1 KRT7 CD34
198 gastrointestinal carcinoma 9.7 KRT20 CEACAM5
199 reproductive organ benign neoplasm 9.7 CEACAM5 CD34
200 urethral villous adenoma 9.7 KRT7 KRT20 CEACAM5
201 seminal vesicle adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
202 urinary bladder villous adenoma 9.7 KRT7 KRT20 CEACAM5
203 bile duct cystadenocarcinoma 9.7 KRT7 KRT20 CEACAM5
204 vulva adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
205 jejunal adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
206 krukenberg carcinoma 9.7 KRT7 KRT20 CEACAM5
207 vaginal tubulovillous adenoma 9.7 KRT7 KRT20 CEACAM5
208 female urethral cancer 9.7 KRT7 KRT20 CEACAM5
209 vulvar apocrine adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
210 vaginal adenoma 9.7 KRT7 KRT20 CEACAM5
211 mucinous ovarian cystadenoma 9.7 KRT7 KRT20 CEACAM5
212 cystadenoma 9.7 KRT7 KRT20 CEACAM5
213 transverse colon cancer 9.7 KRT7 KRT20 CEACAM5
214 malignant syringoma 9.7 KRT7 KRT20 CEACAM5
215 vaginal benign neoplasm 9.7 KRT7 KRT20 CEACAM5
216 appendix adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
217 eccrine sweat gland cancer 9.7 KRT7 KRT20 CEACAM5
218 actinic keratosis 9.7 KRT20 CEACAM5
219 sweat gland cancer 9.7 KRT7 KRT20 CEACAM5
220 urethral benign neoplasm 9.7 KRT7 KRT20 CEACAM5
221 linitis plastica 9.7 KRT7 KRT20 CEACAM5
222 cholangiocarcinoma 9.7 KRT7 KRT20 CEACAM5
223 pancreatic mucinous cystadenoma 9.7 KRT7 KRT20 CEACAM5
224 ovarian mucinous neoplasm 9.7 KRT7 KRT20 CEACAM5
225 appendix disease 9.7 KRT7 KRT20 CEACAM5
226 appendix cancer 9.7 KRT7 KRT20 CEACAM5
227 squamous papillomatosis 9.7 KRT7 KRT20 CEACAM5
228 gastric diffuse adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
229 clear cell basal cell carcinoma 9.7 KRT7 KRT20 CEACAM5
230 ovarian benign neoplasm 9.7 KRT7 KRT20 CEACAM5
231 heart leiomyosarcoma 9.7 PECAM1 MDM2 CD34
232 mucinous bronchioloalveolar adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
233 borst-jadassohn intraepidermal carcinoma 9.7 KRT7 KRT20 CEACAM5
234 benign teratoma 9.7 KRT7 KRT20 CEACAM5
235 teratoma 9.7 KRT7 KRT20 CEACAM5
236 liposarcoma of bone 9.7 PECAM1 MDM2 CD34
237 paget disease, extramammary 9.7 KRT7 KRT20 CEACAM5
238 mucinous cystadenocarcinoma 9.7 KRT7 KRT20 CEACAM5
239 papillary serous adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
240 pseudomyxoma peritonei 9.7 KRT7 KRT20 CEACAM5
241 adenocarcinoma in situ 9.7 KRT7 KRT20 CEACAM5
242 heart sarcoma 9.7 PECAM1 MDM2 CD34
243 rectum adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
244 endocervical adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
245 cervical adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
246 angiolipoma 9.7 PECAM1 MDM2 CD34
247 polycystic liver disease 1 with or without kidney cysts 9.7 KRT7 KRT20 CEACAM5
248 signet ring cell adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
249 cystic teratoma 9.7 KRT7 KRT20 CEACAM5
250 tubular adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
251 vulva cancer 9.7 KRT7 KRT20 CEACAM5
252 bronchiolo-alveolar adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
253 thymic carcinoma 9.7 KRT7 KRT20 CEACAM5
254 mucinous adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
255 connective tissue benign neoplasm 9.7 PECAM1 MDM2 CD34
256 hemangiopericytoma, malignant 9.7 PECAM1 MDM2 CD34
257 large cell carcinoma 9.7 KRT7 KRT20 CEACAM5
258 neuroendocrine carcinoma 9.7 KRT7 KRT20 CEACAM5
259 germ cell and embryonal cancer 9.7 PECAM1 CD34
260 histiocytoma 9.7 PECAM1 MDM2 CD34
261 small cell cancer of the lung 9.7 KRT7 KRT20 CEACAM5
262 colorectal adenocarcinoma 9.7 KRT7 KRT20 CEACAM5
263 gliosarcoma 9.6 PECAM1 MDM2 CD34
264 connective tissue cancer 9.6 PECAM1 MDM2 CD34
265 ampulla of vater cancer 9.6 KRT7 KRT20
266 mesothelioma, malignant 9.6 KRT7 KRT20 CEACAM5
267 skeletal muscle cancer 9.6 MDM2 CD34
268 small intestine cancer 9.6 KRT7 CEACAM5
269 liver sarcoma 9.6 KRT7 CEACAM5 CD34
270 bile duct cancer 9.6 KRT7 KRT20 CEACAM5
271 sarcomatous intrahepatic cholangiocarcinoma 9.6 KRT7 CEACAM5 CD34
272 mediastinal cancer 9.6 KRT7 CEACAM5 CD34
273 uterus leiomyosarcoma 9.6 KRT7 CEACAM5 CD34
274 sweat gland neoplasm 9.6 KRT7 CEACAM5 CD34
275 vulvar disease 9.6 KRT7 CEACAM5 CD34
276 mixed cell type cancer 9.6 KRT7 CEACAM5 CD34
277 ischemic fasciitis 9.6 SAMHD1 MDM2 KRT20 CD34
278 meningioma, familial 9.6 PECAM1 MDM2 CD34
279 clear cell renal cell carcinoma 9.5 PECAM1 MDM2 KRT7
280 cell type benign neoplasm 9.5 KRT7 CEACAM5 CD34
281 liver leiomyoma 9.5 PECAM1 CEACAM5 CD34
282 pulmonary artery leiomyosarcoma 9.5 PECAM1 KRT7 KRT20 CD34
283 cavernous hemangioma 9.5 PECAM1 KRT7 KRT20 CD34
284 vulvar benign neoplasm 9.5 PECAM1 CEACAM5 CD34
285 leber congenital amaurosis 9.4 PECAM1 KRT7 KRT20 CD34
286 angiosarcoma 9.3 PECAM1 MDM2 KRT7 CD34
287 heart cancer 9.3 PECAM1 MDM2 KRT7 CD34
288 adenocarcinoma 9.3 MDM2 KRT7 KRT20 CEACAM5
289 intestinal obstruction 9.3 KRT7 KRT20 CEACAM5 CD34
290 ovary adenocarcinoma 9.3 MDM2 KRT7 KRT20 CEACAM5
291 gastric adenocarcinoma 9.2 MDM2 KRT7 KRT20 CEACAM5
292 endometrial cancer 9.2 MDM2 KRT7 KRT20 CEACAM5
293 benign mesothelioma 9.1 PECAM1 KRT7 CEACAM5 CD34
294 suppression of tumorigenicity 12 9.1 PECAM1 MDM2 KRT7 CEACAM5
295 basal cell carcinoma 8.9 MDM2 KRT7 KRT20 CEACAM5 CD34
296 colonic lymphangioma 8.8 PECAM1 KRT7 KRT20 CEACAM5 CD34
297 thyroid angiosarcoma 8.8 PECAM1 KRT7 KRT20 CEACAM5 CD34
298 adenoid squamous cell carcinoma 8.8 PECAM1 KRT7 KRT20 CEACAM5 CD34
299 lung cancer susceptibility 3 8.8 PECAM1 MDM2 KRT7 KRT20 CEACAM5
300 ovarian cancer 8.3 PECAM1 MDM2 KRT7 KRT20 CEACAM5 CD34

Graphical network of the top 20 diseases related to Aortic Malignant Tumor:



Diseases related to Aortic Malignant Tumor

Symptoms & Phenotypes for Aortic Malignant Tumor

Drugs & Therapeutics for Aortic Malignant Tumor

Search Clinical Trials , NIH Clinical Center for Aortic Malignant Tumor

Genetic Tests for Aortic Malignant Tumor

Anatomical Context for Aortic Malignant Tumor

The Foundational Model of Anatomy Ontology organs/tissues related to Aortic Malignant Tumor:

19
Aorta

MalaCards organs/tissues related to Aortic Malignant Tumor:

40
Breast, Heart, Colon, Lung, Skin, Liver, Appendix

Publications for Aortic Malignant Tumor

Articles related to Aortic Malignant Tumor:

(showing 1, show less)
# Title Authors PMID Year
1
Primary sarcoma of the aorta. 61
1120024 1975

Variations for Aortic Malignant Tumor

Expression for Aortic Malignant Tumor

Search GEO for disease gene expression data for Aortic Malignant Tumor.

Pathways for Aortic Malignant Tumor

Pathways related to Aortic Malignant Tumor according to GeneCards Suite gene sharing:

(showing 1, show less)
# Super pathways Score Top Affiliating Genes
1 11.31 PECAM1 CEACAM5 CD34

GO Terms for Aortic Malignant Tumor

Biological processes related to Aortic Malignant Tumor according to GeneCards Suite gene sharing:

(showing 2, show less)
# Name GO ID Score Top Affiliating Genes
1 leukocyte migration GO:0050900 9.13 PECAM1 CEACAM5 CD34
2 glomerular endothelium development GO:0072011 8.62 PECAM1 CD34

Sources for Aortic Malignant Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....